Suliman Mohamed Ao, Hassan Alnazeer Ma, Kaddam Lamis A
Department of Physiology, Faculty of Medicine, Al Neelain University Khartoum, Sudan.
Am J Blood Res. 2020 Dec 15;10(6):434-439. eCollection 2020.
Sickle Cell Anemia (SCA) is an autosomal recessive haemoglobinopathy with high morbidity and mortality. Global survival of sickle patients is increased due to advances in management; and subsequently, prevalence of chronic complications including renal manifestations also increased. Therefore, early detection and management of these complications is mandatory. This study aimed to investigate the estimated Glomerular Filtration Rate (eGFR), proteinuria and serum uric acid as markers of renal involvement in Sudanese sickle adults and association between these parameters and clinical severity score of sickle cell disease.
Cross-sectional hospital-based study included thirty-two adult Sudanese patients diagnosed with SCA and twenty-three as controls. Written informed consent was obtained from each participant. Blood and urine samples were collected. Severity score was calculated using Bios online calculator and eGFR was calculated using Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula without adjustment for ethnicity. Associations between the severity score and renal parameters were tested using unpaired T test and Mann Whitney test for normally and non-normally distributed data and correlations between variables were tested using SPSS version 23.
Protein/Creatinine Ratio (PCR) was significantly higher (-value < 0.001) in sickle cell anaemia group compared to controls. Hyper-filtration and Hyperuricemia were manifested in 75% and 6.3% of SCA group respectively. There was no association between the severity score and renal manifestations in the SCA group.
Hyper-filtration and proteinuria were the most prevalent renal manifestations in SCA group. Further studies are recommended to determine the predictors of renal complications and ensure early management of such complications.
镰状细胞贫血(SCA)是一种常染色体隐性血红蛋白病,发病率和死亡率很高。由于管理方面的进展,镰状细胞病患者的全球生存率有所提高;随后,包括肾脏表现在内的慢性并发症的患病率也有所增加。因此,必须尽早发现并处理这些并发症。本研究旨在调查估计肾小球滤过率(eGFR)、蛋白尿和血清尿酸,作为苏丹成年镰状细胞病患者肾脏受累的标志物,以及这些参数与镰状细胞病临床严重程度评分之间的关联。
基于医院的横断面研究纳入了32名被诊断为SCA的成年苏丹患者和23名作为对照的患者。从每位参与者处获得书面知情同意书。采集血液和尿液样本。使用Bios在线计算器计算严重程度评分,使用慢性肾脏病流行病学协作组(CKD-EPI)公式计算eGFR,不针对种族进行调整。对于正态分布和非正态分布的数据,分别使用非配对t检验和曼-惠特尼检验来检验严重程度评分与肾脏参数之间的关联,并使用SPSS 23版来检验变量之间的相关性。
与对照组相比,镰状细胞贫血组的蛋白/肌酐比值(PCR)显著更高(p值<0.001)。SCA组分别有75%和6.3%的患者出现高滤过和高尿酸血症。SCA组的严重程度评分与肾脏表现之间无关联。
高滤过和蛋白尿是SCA组最常见的肾脏表现。建议进一步开展研究以确定肾脏并发症的预测因素,并确保对这些并发症进行早期处理。